Chemo-resistance-related genes detected by cDNA microarray

cDNA微阵列检测化疗耐药相关基因

基本信息

  • 批准号:
    14571225
  • 负责人:
  • 金额:
    $ 2.56万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2004
  • 项目状态:
    已结题

项目摘要

To identify chemoresistance-related genes of gastric cancer, we utilized cDNA microarray technology. Thirty-five gastric cancer specimens surgically resected at our institute between 1998 and 1999 were studied for quantification of 6,300 gene expression by means of oligonucleotide microarray methods, and the calculated gene expressions were evaluated comparing with chemoresistance of each specimens, which was determined by MTT assay (the tetrazolium-based 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-tetrazolium bromide assay). Inhibition rates (IR) were determined for cisplatin (DDP), 5-fluorouracil (5-FU), mitomycin C or doxorubicin. IR more than or equal to 60% was regarded as sensitive to each agent, and IR less than 40% defined as resistant. Clustering was successfully completed for DDP, resulting in selection of 23 candidates as DDP resistance-related genes, including vascular permeability factor, 2 membrane transporting subunits, and retinoblastoma-binding protein-1. In addition, fur … More ther selection of the DDP resistance-related genes was performed following to these two criteria ; 1)Expression of its gene can be detected in more than 70% of the resistant tumors. 2)Expression detected in less than 30% of the sensitive tumors. 3)Expression levels in tumors twice that of normal mucosa in more than 50% of specimens. Then, metallothionein-IG and heparin-binding epidermal growth factor-like growth factor (HB-EGF) were identified as candidates of DDP-resistance-related genes. When known resistance-related genes to DDP were analyzed according to the MTT assay result, a family of glutathione-S-transferase and cyclooxygenase-2 genes were also evaluated as resistance-related genes. For 5-FU resistance, expression of dihydropyiimidine dehydrogenase and heparin-binding EGF-like growth factor genes were also suggested to be 5-FU resistance-related genes. The present study demonstrated that oligonucleotide microarrays would be useful in providing further information regarding chemoresistant-factors in cancer. Less
为了筛选胃癌耐药相关基因,我们利用cDNA微阵列技术。应用寡核苷酸芯片技术对1998 ~ 1999年在我所手术切除的35例胃癌标本进行了6,300个基因表达的定量分析,并与MTT法测定的各标本化疗耐药性进行比较(基于四唑鎓的3-(4,5-二甲基噻唑-2基)-2,5-二苯基-溴化四唑鎓测定)。测定顺铂(DDP)、5-氟尿嘧啶(5-FU)、丝裂霉素C或阿霉素的抑制率(IR)。IR ≥ 60%为敏感,IR <40%为耐药。成功完成了DDP的聚类,从而选择了23个候选基因作为DDP耐药相关基因,包括血管通透性因子、2个膜转运亚基和视网膜母细胞瘤结合蛋白-1。此外,Fur ...更多信息 根据以下两个标准进行DDP耐药相关基因的筛选:1)在70%以上的耐药肿瘤中可检测到其基因的表达。2)在不到30%的敏感肿瘤中检测到表达。3)在超过50%的标本中,肿瘤中的表达水平是正常粘膜的两倍。金属硫蛋白-IG和肝素结合表皮生长因子样生长因子(HB-EGF)被确定为DDP耐药相关基因的候选基因。当根据MTT试验结果分析已知的DDP耐药相关基因时,谷胱甘肽-S-转移酶和环氧合酶-2基因家族也被评估为耐药相关基因。对于5-FU耐药,二氢嘧啶脱氢酶和肝素结合EGF样生长因子基因的表达也被认为是5-FU耐药相关基因。本研究表明,寡核苷酸芯片将是有用的,在提供进一步的信息,化疗耐药因素在癌症。少

项目成果

期刊论文数量(52)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Real timeRT-PCR(Taqman【◯!R】) of tumor mRNA to predict sensitivity of specimens to 5-fluorouracil
肿瘤mRNA实时RT-PCR(Taqman【◯!R】)预测标本对5-氟尿嘧啶的敏感性
久保田哲朗: "抗癌剤感受性試験-細胞生物学的・分子生物学的手法"医薬ジャーナル. 39(3). 55-61 (2003)
Tetsuro Kubota:“抗癌药物敏感性测试-细胞生物学和分子生物学方法”Pharmaceutical Journal 39(3) (2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
久保田哲朗: "消化器癌の現状と問題点:胃癌は減少しているか"日本医師会雑誌. 127. 1662-1665 (2002)
Tetsuro Kubota:“胃肠癌的现状和问题:胃癌正在减少吗?” 日本医学会杂志 127. 1662-1665 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Inhibition of DNA methyltransferase by antisense oligodeoxynucleotide modifies cell characteristics in gastric cancer cell lines.
  • DOI:
    10.3892/or.12.3.527
  • 发表时间:
    2004-09
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Y. Saikawa;T. Kubota;Shingo Maeda;Y. Otani;K. Kumai;M. Kitajima
  • 通讯作者:
    Y. Saikawa;T. Kubota;Shingo Maeda;Y. Otani;K. Kumai;M. Kitajima
in vivo抗がん剤感受性試験
体内抗癌药物药敏试验
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    久保田哲朗
  • 通讯作者:
    久保田哲朗
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUBOTA Tetsuro其他文献

KUBOTA Tetsuro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUBOTA Tetsuro', 18)}}的其他基金

Novel chmosensitivity testing using molecular dynamics responding to anticancer drugs
利用对抗癌药物的分子动力学进行新型化学敏感性测试
  • 批准号:
    17591435
  • 财政年份:
    2005
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New strategy in cancel therapy with reference tomethionine-depletion
参考蛋氨酸消耗的取消治疗新策略
  • 批准号:
    07671329
  • 财政年份:
    1995
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cloning of suppressor gene of metastasis using subtraction hybridization method
消减杂交法克隆转移抑制基因
  • 批准号:
    05671026
  • 财政年份:
    1993
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Comparative study of concentrations of antitumor agents in serum and tumor in nude mouse and human
裸鼠与人血清及肿瘤中抗肿瘤药物浓度的比较研究
  • 批准号:
    62570579
  • 财政年份:
    1987
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Attempt to stratify gastric cancer patients by AI using general clinical information
尝试利用一般临床信息通过人工智能对胃癌患者进行分层
  • 批准号:
    23K08102
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
stablishment of non-invasive DNA methylation panel for peritoneal metastasis of gastric cancer patients
胃癌腹膜转移非侵入性DNA甲基化检测试剂盒的建立
  • 批准号:
    23K08210
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development a novel immnunotherapy for gastric cancer by targeted SMARCA4
通过靶向 SMARCA4 开发一种新型胃癌免疫疗法
  • 批准号:
    23K15047
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status
社会经济地位较低的非裔美国人和欧洲白人胃癌风险的前瞻性代谢组学调查
  • 批准号:
    10912190
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
Development of Gastric Cancer Therapy Targeting Pyruvate Metabolism
针对丙酮酸代谢的胃癌治疗的进展
  • 批准号:
    22KJ1826
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
The clinical impact of drug holiday in treatment of metastatic gastric cancer
药物假期对转移性胃癌治疗的临床影响
  • 批准号:
    23K09533
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Computational imaging approaches to personalized gastric cancer treatment
个性化胃癌治疗的计算成像方法
  • 批准号:
    10585301
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
Prospective study on the diagnostic accuracy of early gastric cancer by serum methylated RUNX3
血清甲基化RUNX3诊断早期胃癌准确性的前瞻性研究
  • 批准号:
    23K06910
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effect of ant-claudin antibody against peritoneal metastasis from gastric cancer
抗密蛋白抗体对抗胃癌腹膜转移的作用
  • 批准号:
    23K19642
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of a Novel Cancer Therapy Strategy Targeting TGFBI in Gastric Cancer Stroma
开发针对胃癌基质中 TGFBI 的新型癌症治疗策略
  • 批准号:
    23K15513
  • 财政年份:
    2023
  • 资助金额:
    $ 2.56万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了